📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission. (2010)

First Author: Gorin NC

Attributed to: Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2009-11-252197

PubMed Identifier: 20479285

Publication URI: http://europepmc.org/abstract/MED/20479285

Type: Journal Article/Review

Volume: 116

Parent Publication: Blood

Issue: 17

ISSN: 0006-4971